AAAAAA

   
Results: 1-20 |
Results: 20
ENHANCED EFFICACY OF B16-ALPHA CELLS AS A TUMOR VACCINE IN MICE IS MEDIATED BY MACROPHAGES AND T-CELLS AND MAY INVOLVE BREAKING TOLERANCE
Authors: WU TY FLEISCHMANN WR
Citation: Ty. Wu et Wr. Fleischmann, ENHANCED EFFICACY OF B16-ALPHA CELLS AS A TUMOR VACCINE IN MICE IS MEDIATED BY MACROPHAGES AND T-CELLS AND MAY INVOLVE BREAKING TOLERANCE, European cytokine network, 9(3), 1998, pp. 230-230
EFFICACY OF B16 MELANOMA-CELLS EXPOSED IN-VITRO TO LONG-TERM IFN-ALPHA TREATMENT (B16-ALPHA CELLS) AS A TUMOR VACCINE IN MICE
Authors: WU TY FLEISCHMANN WR
Citation: Ty. Wu et Wr. Fleischmann, EFFICACY OF B16 MELANOMA-CELLS EXPOSED IN-VITRO TO LONG-TERM IFN-ALPHA TREATMENT (B16-ALPHA CELLS) AS A TUMOR VACCINE IN MICE, Journal of interferon & cytokine research, 18(10), 1998, pp. 829-839
ORALLY-ADMINISTERED IFN-ALPHA ACTS ALONE AND IN SYNERGISTIC COMBINATION WITH INTRAPERITONEALLY ADMINISTERED IFN-GAMMA TO EXERT AN ANTITUMOREFFECT AGAINST B16 MELANOMA IN MICE
Authors: FLEISCHMANN WR MASOOR J WU TY FLEISCHMANN CM
Citation: Wr. Fleischmann et al., ORALLY-ADMINISTERED IFN-ALPHA ACTS ALONE AND IN SYNERGISTIC COMBINATION WITH INTRAPERITONEALLY ADMINISTERED IFN-GAMMA TO EXERT AN ANTITUMOREFFECT AGAINST B16 MELANOMA IN MICE, Journal of interferon & cytokine research, 18(1), 1998, pp. 17-20
OBITUARY - FLEISCHMANN,CHRISTINA,M
Authors: FLEISCHMANN WR
Citation: Wr. Fleischmann, OBITUARY - FLEISCHMANN,CHRISTINA,M, Journal of interferon & cytokine research, 17(4), 1997, pp. 179-179
B16 MELANOMA-CELLS EXPOSED IN-VITRO TO LONG-TERM IFN-ALPHA TREATMENT (B16-ALPHA CELLS) AS ACTIVATORS OF TUMOR-IMMUNITY IN MICE
Authors: FLEISCHMANN CM WU TY FLEISCHMANN WR
Citation: Cm. Fleischmann et al., B16 MELANOMA-CELLS EXPOSED IN-VITRO TO LONG-TERM IFN-ALPHA TREATMENT (B16-ALPHA CELLS) AS ACTIVATORS OF TUMOR-IMMUNITY IN MICE, Journal of interferon & cytokine research, 17(1), 1997, pp. 37-43
LACK OF MDA-6 WAF1/CIP1-MEDIATED INHIBITION OF CYCLIN-DEPENDENT KINASES IN INTERFERON-ALPHA RESISTANT MURINE B16 MELANOMA-CELLS/
Authors: ARANY I FLEISCHMANN CM TYRING SK FLEISCHMANN WR
Citation: I. Arany et al., LACK OF MDA-6 WAF1/CIP1-MEDIATED INHIBITION OF CYCLIN-DEPENDENT KINASES IN INTERFERON-ALPHA RESISTANT MURINE B16 MELANOMA-CELLS/, Cancer letters, 119(2), 1997, pp. 237-240
INTERFERON REGULATES EXPRESSION OF MDA-6 WAF1/CIP1 AND CYCLIN-DEPENDENT KINASES INDEPENDENTLY FROM P53 IN B16 MURINE MELANOMA-CELLS/
Authors: ARANY I FLEISCHMANN CM TYRING SK FLEISCHMANN WR
Citation: I. Arany et al., INTERFERON REGULATES EXPRESSION OF MDA-6 WAF1/CIP1 AND CYCLIN-DEPENDENT KINASES INDEPENDENTLY FROM P53 IN B16 MURINE MELANOMA-CELLS/, Biochemical and biophysical research communications, 233(3), 1997, pp. 678-680
ENHANCED IN-VIVO SENSITIVITY OF IN-VITRO INTERFERON-TREATED B16 MELANOMA-CELLS TO CD8 CELLS AND ACTIVATED MACROPHAGES
Authors: FLEISCHMANN CM STANTON GJ FLEISCHMANN WR
Citation: Cm. Fleischmann et al., ENHANCED IN-VIVO SENSITIVITY OF IN-VITRO INTERFERON-TREATED B16 MELANOMA-CELLS TO CD8 CELLS AND ACTIVATED MACROPHAGES, Journal of interferon & cytokine research, 16(10), 1996, pp. 805-812
ORAL APPLICATION OF CYTOKINES
Authors: GEORGIADES JA FLEISCHMANN WR
Citation: Ja. Georgiades et Wr. Fleischmann, ORAL APPLICATION OF CYTOKINES, Biotherapy, 8(3-4), 1996, pp. 205-212
ENHANCED IN-VITRO MACROPHAGE CYTOTOXICITY AGAINST INTERFERON-TREATED B16 MELANOMA-CELLS
Authors: FLEISCHMANN CM FLEISCHMANN WR
Citation: Cm. Fleischmann et Wr. Fleischmann, ENHANCED IN-VITRO MACROPHAGE CYTOTOXICITY AGAINST INTERFERON-TREATED B16 MELANOMA-CELLS, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 139-145
INTERACTIONS OF INTERFERON AND VINBLASTINE ON EXPERIMENTAL TUMOR-MODEL MELANOMA-B-16 IN-VITRO
Authors: JEZERSEK B NOVAKOVIC S SERSA G AUERSPERG M FLEISCHMANN WR
Citation: B. Jezersek et al., INTERACTIONS OF INTERFERON AND VINBLASTINE ON EXPERIMENTAL TUMOR-MODEL MELANOMA-B-16 IN-VITRO, Anti-cancer drugs, 5(1), 1994, pp. 53-56
ENHANCEMENT OF MUIFN-GAMMA ANTITUMOR EFFECTS BY HYPERTHERMIA - SEQUENCE DEPENDENCE AND TIME-DEPENDENCE OF HYPERTHERMIA
Authors: FLEISCHMANN WR FLEISCHMANN CM
Citation: Wr. Fleischmann et Cm. Fleischmann, ENHANCEMENT OF MUIFN-GAMMA ANTITUMOR EFFECTS BY HYPERTHERMIA - SEQUENCE DEPENDENCE AND TIME-DEPENDENCE OF HYPERTHERMIA, Journal of biological regulators and homeostatic agents, 8(4), 1994, pp. 101-107
ENHANCED IN-VIVO SENSITIVITY TO INTERFERON WITH IN-VITRO RESISTANT B16 TUMOR-CELLS IN MICE
Authors: FLEISCHMANN CM STANTON GJ FLEISCHMANN WR
Citation: Cm. Fleischmann et al., ENHANCED IN-VIVO SENSITIVITY TO INTERFERON WITH IN-VITRO RESISTANT B16 TUMOR-CELLS IN MICE, Cancer immunology and immunotherapy, 39(3), 1994, pp. 148-154
MODULATION OF PERIPHERAL LEUKOCYTE COUNTS AND BONE-MARROW FUNCTION INMICE BY ORAL-ADMINISTRATION OF INTERLEUKIN-2
Authors: KOREN S FLEISCHMANN WR
Citation: S. Koren et Wr. Fleischmann, MODULATION OF PERIPHERAL LEUKOCYTE COUNTS AND BONE-MARROW FUNCTION INMICE BY ORAL-ADMINISTRATION OF INTERLEUKIN-2, Journal of interferon research, 14(6), 1994, pp. 343-347
CIRCADIAN DEPENDENCE OF INTERFERON ANTITUMOR-ACTIVITY IN MICE
Authors: KOREN S WHORTON EB FLEISCHMANN WR
Citation: S. Koren et al., CIRCADIAN DEPENDENCE OF INTERFERON ANTITUMOR-ACTIVITY IN MICE, Journal of the National Cancer Institute, 85(23), 1993, pp. 1927-1932
PREVENTION OF RESISTANCE TO IFN-ALPHA ANTIPROLIFERATIVE ACTIVITY - CHARACTERIZATION OF THE EFFECT OF IFN-GAMMA AND SUBSTITUTION FOR IFN-GAMMA BY TUMOR-NECROSIS-FACTOR
Authors: FLEISCHMANN CM STANTON GJ FLEISCHMANN WR
Citation: Cm. Fleischmann et al., PREVENTION OF RESISTANCE TO IFN-ALPHA ANTIPROLIFERATIVE ACTIVITY - CHARACTERIZATION OF THE EFFECT OF IFN-GAMMA AND SUBSTITUTION FOR IFN-GAMMA BY TUMOR-NECROSIS-FACTOR, Journal of biological regulators and homeostatic agents, 7(2), 1993, pp. 50-57
CIRCADIAN VARIATIONS IN MYELOSUPPRESSIVE ACTIVITY OF INTERFERON-ALPHAIN MICE - IDENTIFICATION OF AN OPTIMAL TREATMENT TIME ASSOCIATED WITHREDUCED MYELOSUPPRESSIVE ACTIVITY
Authors: KOREN S FLEISCHMANN WR
Citation: S. Koren et Wr. Fleischmann, CIRCADIAN VARIATIONS IN MYELOSUPPRESSIVE ACTIVITY OF INTERFERON-ALPHAIN MICE - IDENTIFICATION OF AN OPTIMAL TREATMENT TIME ASSOCIATED WITHREDUCED MYELOSUPPRESSIVE ACTIVITY, Experimental hematology, 21(4), 1993, pp. 552-559
OPTIMAL CIRCADIAN TIMING REDUCES THE MYELOSUPPRESSIVE ACTIVITY OF RECOMBINANT MURINE INTERFERON-GAMMA ADMINISTERED TO MICE
Authors: KOREN S FLEISCHMANN WR
Citation: S. Koren et Wr. Fleischmann, OPTIMAL CIRCADIAN TIMING REDUCES THE MYELOSUPPRESSIVE ACTIVITY OF RECOMBINANT MURINE INTERFERON-GAMMA ADMINISTERED TO MICE, Journal of interferon research, 13(3), 1993, pp. 187-195
HYPOXIA ENHANCES THE ANTIVIRAL ACTIVITY OF INTERFERONS
Authors: NALDINI A CARRARO F FLEISCHMANN WR BOCCI V
Citation: A. Naldini et al., HYPOXIA ENHANCES THE ANTIVIRAL ACTIVITY OF INTERFERONS, Journal of interferon research, 13(2), 1993, pp. 127-132
ORALLY-ADMINISTERED INTERFERONS SUPPRESS BONE-MARROW FUNCTION
Authors: KOREN S FLEISCHMANN WR
Citation: S. Koren et Wr. Fleischmann, ORALLY-ADMINISTERED INTERFERONS SUPPRESS BONE-MARROW FUNCTION, Proceedings of the Society for Experimental Biology and Medicine, 204(2), 1993, pp. 155-164
Risultati: 1-20 |